Results 281 to 290 of about 20,272,350 (403)
1088 CLINICAL CORRELATIONS OF CSF ENDOTOXIN-LIKE ACTIVITY IN GRAM-NEGATIVE MENINGITIS [PDF]
, 1985 Terry L Dwelle +3 more
openalex +1 more source
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source
Assessment of activity in SLE: a clinical and serological study.
, 1975 Jason Edmonds, C Bruneau, G R Hughes
openalex +1 more source
Temperatures Used in the Determination of Enzyme Activity in Clinical Biochemistry Laboratories in Britain: Results of a Survey [PDF]
, 1982 A. Fleck, C M Colley
openalex +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source
In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centers [PDF]
, 1985 Ronald N. Jones +4 more
openalex +1 more source
Clinical Appraisal of the Activity Index as a Measure of Rheumatoid Activity [PDF]
Arthritis & Rheumatism, 1968 openaire +3 more sources
Molecular Oncology, EarlyView.TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach +8 more
wiley +1 more source
Molecular Oncology, EarlyView.Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner +6 more
wiley +1 more source